Company Search:
Advanced Search
Sponsored Links
Abbott Laboratories (Pakistan) Ltd Company Snapshot
Abbott Laboratories (Pakistan) Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories (Pakistan) Ltd with three other companies in this sector in PAKISTAN : Searle Co Ltd (2020 sales of 20.47 billion Pakistan Rupees [US$118.55 million] ), Glaxosmithkline Consumer Healthcare Pakistan Ltd (19.85 billion Pakistan Rupees [US$114.91 million] of which 100% was Consumer HealthCare), and GlaxoSmithKline Pakistan Limited (35.09 billion Pakistan Rupees [US$203.17 million] ).

Sales Analysis. During the second quarter of 2021, sales at Abbott Laboratories (Pakistan) Ltd totalled 10.91 billion Pakistan Rupees . This is an increase of 28.7% from the 8.47 billion Pakistan Rupees in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled 20.80 billion Pakistan Rupees , which is 25.8% higher than through the first two quarters of 2020. During the previous 6 quarters, sales at Abbott Laboratories (Pakistan) Ltd have increased compared with the same quarter in the previous year. There appears to be at least some degree of seasonality in the sales at Abbott Laboratories (Pakistan) Ltd: during 7 of the previous 8 years, sales were highest during the fourth quarter. The exception to this was during 2019, when the second quarter was the best quarter, accounting for 27% of sales (during that same year, the fourth quarter accounted for 26% of sales). During the year ended December of 2020, sales at Abbott Laboratories (Pakistan) Ltd were 35.28 billion Pakistan Rupees (US$204.29 million). This is an increase of 17.0% versus 2019, when the company's sales were 30.16 billion Pakistan Rupees . This was the fifth consecutive year of sales increases at Abbott Laboratories (Pakistan) Ltd (and since 2015, sales have increased a total of 67%). Sales of Nutritional saw an increase that was more than double the company's growth rate: sales were up 37.5% in 2020, from 6.20 billion Pakistan Rupees to 8.53 billion Pakistan Rupees . Not all segments of Abbott Laboratories (Pakistan) Ltd experienced an increase in sales in 2020: sales of Other fell 73.6% to 727.25 million Pakistan Rupees .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Abbott Laboratories (Pakistan) Ltd
  Stock Performance Chart for Abbott Laboratories (Pakistan) Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/15/2021): 780.00
(Figures in Pakistan Rupees )
1 Week 0.9%   13 Weeks 2.5%  
4 Weeks 2.2%   52 Weeks 4.3%  
Abbott Laboratories (Pakistan) Ltd Key Data:
  Ticker: ABOT Country: Pakistan
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 35,283,377,000
(Year Ending Jan 2021).
Employees: 1,464
  Currency: Pakistan Rupees Market Cap: 76,362,235,560
  Fiscal Yr Ends: December Shares Outstanding: 97,900,302
  Share Type: Ordinary Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.